Literature DB >> 22795963

Patients with nontuberculous mycobacteria: comparison of updated and previous diagnostic criteria for lung disease.

Erin Epson1, Maureen Cassidy, Angela Marshall-Olson, Katrina Hedberg, Kevin L Winthrop.   

Abstract

We classified patients with respiratory nontuberculous mycobacteria (NTM) isolates using updated (2007) and previous (1997) American Thoracic Society/Infectious Diseases Society of America criteria for NTM lung disease. We found that a greater proportion of such patients have disease using updated criteria due to improved sensitivity of the microbiologic component of the disease definition.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22795963     DOI： 10.1016/j.diagmicrobio.2012.05.035

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  7 in total

1.  In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

2.  Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.

Authors:  Andrés Obregón-Henao; Kimberly A Arnett; Marcela Henao-Tamayo; Lisa Massoudi; Elizabeth Creissen; Koen Andries; Anne J Lenaerts; Diane J Ordway
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

3.  Host response to nontuberculous mycobacterial infections of current clinical importance.

Authors:  Ian M Orme; Diane J Ordway
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

4.  Successful management of Mycobacterium abscessus complex lung disease in an otherwise healthy infant.

Authors:  Hui Liu; Fang Dong; Jinrong Liu; Jianhua Liu; Yu Pang; Shunying Zhao; Jie Lu; Huimin Li
Journal:  Infect Drug Resist       Date:  2019-05-15       Impact factor: 4.003

5.  The effects of sildenafil on ciliary beat frequency in patients with pulmonary non-tuberculous mycobacteria disease: phase I/II trial.

Authors:  Cedar Fowler; Un-In Wu; Robyn Shaffer; Caroline Smith; Lisa Barnhart; Clare Bryant; Kenneth Olivier; Steven M Holland
Journal:  BMJ Open Respir Res       Date:  2020-03

6.  TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.

Authors:  Jickky Palmae Sarathy; Uday S Ganapathy; Matthew D Zimmerman; Véronique Dartois; Martin Gengenbacher; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 7.  Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.

Authors:  Deepshikha Verma; Edward D Chan; Diane J Ordway
Journal:  Vaccines (Basel)       Date:  2020-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.